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Abstract. 
 
This study illuminates the intra-nuclear fate 
of COL1A1 RNA in osteogenesis imperfecta (OI) Type 
I. Patient ﬁbroblasts were shown to carry a heterozy-
gous defect in splicing of intron 26, blocking mRNA ex-
port. Both the normal and mutant allele associated with 
a nuclear RNA track, a localized accumulation of post-
transcriptional RNA emanating to one side of the gene. 
Both tracks had slightly elongated or globular morphol-
ogy, but mutant tracks were cytologically distinct in that 
they lacked the normal polar distribution of intron 26. 
Normal COL1A1 RNA tracks distribute throughout an 
SC-35 domain, from the gene at the periphery. Nor-
mally, almost all 50 COL1A1 introns are spliced at or 
adjacent to the gene, before mRNA transits thru the 
domain. Normal COL1A1 transcripts may undergo 
maturation needed for export within the domain such 
as removal of a slow-splicing intron (shown for intron 
24), after which they may disperse. Splice-defective 
transcripts still distribute thru the SC-35 domain, mov-
 
ing 
 
z
 
1–3 
 
m
 
m from the gene. However, microﬂuorimet-
ric analyses demonstrate mutant transcripts accumulate 
to abnormal levels within the track and domain. Hence, 
mutant transcripts initiate transport from the gene, but 
are impeded in exit from the SC-35 domain. This identi-
ﬁes a previously undeﬁned step in mRNA export, in-
volving movement through an SC-35 domain. A model 
is presented in which maturation and release for export 
of COL1A1 mRNA is linked to rapid cycling of meta-
bolic complexes within the splicing factor domain,
adjacent to the gene. This paradigm may apply to SC-35 
domains more generally, which we suggest may be nu-
 
cleated at sites of high demand and comprise factors being 
actively used to facilitate expression of associated loci.
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Introduction
 
Knowledge of how RNA transcription, processing and
selective export are integrated into the dense structure of
the interphase nucleus is important for understanding
both normal mRNA metabolism and defects in many ge-
netic diseases. Work presented here investigates the in-
terrelationship of RNA metabolism and nuclear struc-
ture in normal and mutant cells, by examining the fate
of COL1A1 transcripts in osteogenesis imperfecta (OI)
 
1
 
Type I where a heterozygous mutation impacts the splic-
ing and, as shown here, the transport of this mRNA. In so
doing, this study also illuminates two fundamental but de-
bated aspects of nuclear structure, concerning the relation-
ship of SC-35 domains to pre-mRNA metabolism, and the
existence of posttranscriptional RNA tracks.
OI is caused by mutations in the collagen type I genes
that result in a wide range of phenotypes (Byers and
Steiner, 1992). Mutant RNA studied here from a patient
with OI type I (patient 054) was found to carry a G-A
transition in the splice site of intron 26, identical to a muta-
tion reported earlier from another OI Type I patient (053)
(Stover et al., 1993). The mutant RNA retains intron 26,
which also introduces a frame-shift and downstream non-
sense codons. The mutant transcripts are detected in the
nucleus but not the cytoplasm (this study and Genovese
et al., 1989; Genovese and Rowe, 1987). In the heterozy-
gous state this mutation results in lower levels of Type I
collagen and a mild disorder characterized by nondeform-
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ing recurrent bone fractures, typical of OI Type I (Byers and
Steiner, 1992). However, other mutants in which defective
COL1A1 RNA is expressed in the cytoplasm can cause a
much more severe (OI Type III) or lethal (OI Type II) dis-
ease (reviewed in Rowe, 1991; Kuivaniemi et al., 1991; By-
ers and Steiner, 1992). Hence, in OI, as in many diseases,
the question of whether mutant RNA will be transported
from the nucleus and expressed in the cytoplasm is critical
to the clinical outcome.
Nuclear retention of a defective RNA could result from
either a lack of factors that promote export or the pres-
ence of factors that prevent nuclear release of transcripts,
or both (reviewed in: Goldfarb, 1989; Elliott et al., 1994;
Izaurralde and Mattaj, 1995; Nakielny et al., 1997; see also
Jarmolowski et al., 1994). A connection between pre-mRNA
splicing and nuclear-cytoplasmic transport had been sug-
gested previously (Legrain and Rosbash, 1989; Chang and
Sharp, 1989), and a very recent study provides detailed
demonstration of such a link (Luo and Reed, 1999). Hence,
retention of intron 26 might disrupt nuclear transport of
mutant transcripts. It was also possible that this COL1A1
mutant RNA would be rapidly degraded due to non-sense
mediated decay which studies of some mammalian mRNAs
report can occur in the nucleus (reviewed
 
 
 
in Jacobson and
Peltz, 1996; Maquat, 1995; see also Willing et al., 1996; Pri-
morac et al., 1999). Results presented here show that mu-
tant transcripts retaining intron 26 accumulate within the
nucleus and have a longer nuclear half-life, indicating a de-
fect in RNA transport. To understand where and how such
an impediment to transport might occur, it is necessary to
examine the fate of transcripts directly in the context of
cell and nuclear structure, as undertaken here. Importantly,
the human COL1A1 transcripts are visualized within indi-
vidual nuclei of heterozygous cells where both normal and
mutant alleles are simultaneously expressed in native struc-
tural and physiological context.
Although nuclear export is often thought of in terms of
transport across the nuclear envelope, this is but one pos-
sible site where a transport block may occur. For exam-
ple, in some yeast mutants implicated in RNA export,
poly(A)RNA accumulated in the nucleolus (Kadowaki et al.,
1995) whereas in others it accumulated in granular struc-
tures or at the nuclear periphery (reviewed in Izaurralde
and Mattaj, 1995). Since splicing can be cotranscriptional
(Osheim et al., 1985; Bauren and Wieslander, 1994) and
splicing factors and RNA Pol II apparently form part of
the same complex (Mortillaro et al., 1996; Kim et al.,
1997), splice-defective RNA could fail to detach from the
gene, as recently proposed (Custodio et al., 1999). Alter-
natively, mutant transcripts could disperse widely or accu-
mulate in any of various intra-nuclear compartments.
Recent findings from several labs have heightened inter-
est in different intra-nuclear compartments enriched in
distinct sets of macromolecules, such as SC-35 domains or
speckles, PML domains, and coiled bodies (Raska et al.,
1991; Ascoli and Maul, 1991; Spector, 1993; Moen et al.,
1995b). Of particular relevance here is the compartment
rich in poly(A)RNA and various pre-mRNA metabolic
factors, such as spliceosome assembly factor SC-35 (Fu and
Maniatis, 1990; reviewed in Spector, 1993; Lawrence et al.,
1993; Fakan, 1994). The term SC-35 domains specifies the
20–40 large (0.5–3.0 
 
m
 
m) globular domains observed by anti-
SC-35 immunofluorescence, as distinct from the broader
snRNP speckled pattern that includes coiled bodies and
various smaller snRNP entities. Much evidence indicates
that SC-35 domains correspond largely if not entirely to
the electron microscopic structures termed inter-chroma-
tin granule clusters (IGC; Fakan and Puvion, 1980; Visa et al.,
1993). These structures have long been believed to be stor-
age sites of excess factors devoid of short-lived RNA,
based on their apparent lack of uridine incorporation, as
seen with EM and fluorescence assays (e.g., Fakan and Pu-
vion, 1980; Wansink et al., 1993).
We have been investigating the idea that endogenous
gene loci may have specific spatial arrangements relative
to discrete domains of abundant metabolic factors. While
transcription clearly occurs throughout the nucleoplasm
(previously cited references and Jackson et al., 1993),
statistical analysis of 
 
z
 
20 endogenous genes/RNAs has
shown that a substantial subset of genes expressing pre-
mRNA localize with high frequency (70–99%) in the pe-
riphery of an SC-35–rich domain (Xing et al., 1993, 1995;
Moen et al., 1995a; Smith et al., 1999). One interpretation
might be that the accumulated factors were recruited from
distant storage sites to a randomly located active gene.
However, a variety of observations led us to suggest a
more complex structural arrangement, whereby some ac-
tive chromosomal loci are intimately associated with do-
mains of abundant metabolic factors (Lawrence et al.,
1993; Smith et al., 1999). This hypothesis is not in itself in-
consistent with the possibility of the domain interior being
devoid of new transcripts, especially since many (pre)-
mRNAs that associate with domains are detected at the
periphery, not necessarily throughout the domain (e.g.,
Xing et al., 1993).
A more puzzling case is presented by several individual
(pre)-mRNAs, such as COL1A1, which are consistently
seen throughout the interior of an SC-35 domain (Xing et al.,
1995; Smith et al., 1999), as well as by the observation of
adenovirus transcripts within the IGC (Bridge et al., 1996).
A fundamental question then becomes, are some fluores-
cent domains purely stores of inert splicing factors and
others accumulated factors on nascent transcripts of a
highly expressed gene? Or, might individual SC-35 do-
mains contain both a disproportionate excess of splicing
factors as well as specific newly synthesized RNAs?
For COL1A1, the idea that transcripts might move from
a gene positioned at the periphery into the SC35 domain is
closely related to another debated concept, regarding
posttranscriptional RNA tracks. We use the term RNA
track to denote a localized accumulation of detached tran-
scripts that extends beyond and to one side of the gene, il-
luminating an early step in the RNA export path. The key
point is that an RNA track contains detached transcripts
in transit from the gene, as distinct from a tree of nascent
transcripts still attached to the gene. The term track is not
intended to imply a prefixed linear or vectorial structure
along which transcripts must travel (analogous to a train
track). Tracks seen for different RNAs in different cells may
have quite distinct structural bases; for example tracks for
several cellular mRNAs are less elongated and tightly lo-
calized than tracks of some viral RNAs (Lawrence et al.,
1989; Xing et al., 1995; Lampel et al., 1997; Melcak et al.,
2000). Though not seen for all (pre)-mRNAs (discussed in 
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Xing and Lawrence, 1993), RNA tracks extending from
one side of the gene, hypothesized to contain posttran-
scriptional transcripts, have now been reported from mul-
tiple labs for several cellular and viral RNAs (previously
cited references and Xing et al., 1993;
 
 
 
Huang and Spector,
1991; Raap et al., 1991). In contrast, for other RNAs only
random dispersal through the nucleoplasm was observed
(e.g., Zachar et al., 1993;
 
 
 
Politz et al., 1998; Singh et al.,
1999; reviewed in Daneholt, 1999). Consequently, despite
major differences in the RNAs and cell-types studied,
there has remained debate as to whether putative post-
transcriptional tracks of released transcripts are really just
Christmas trees of nascent transcripts attached to a highly
decondensed active gene (e.g., Zachar et al., 1993; Kramer
et al., 1994).
Here detailed investigations of normal and splice-defec-
tive COL1A1 transcripts define the intranuclear fate of
mutant transcripts in OI patient cells, but also provide a
critical test of the interpretation of RNA tracks. To extend
our analyses we devised a strategy to examine the cumula-
tive distribution of the 50 introns in COL1A1 RNA, pro-
viding a fuller understanding of the relationship of both
the RNA tracks and SC-35 domains to the splicing and
transport of normal and mutant COL1A1 RNA.
 
Materials and Methods
 
Cell Culture, Fractionation, and Immunofluorescence
 
Fibroblast cultures were previously established from dermal biopsies of
AE, an 11-yr-old male (cell line 054), and a 13-yr-old female (cell line 053;
Rowe et al., 1985). These and WI38 human diploid lung fibroblasts
(ATCC) were grown in DME, high glucose with 10–20% FCS, 2 mM 
 
L
 
-Glut,
and 1% Pen/Strep. Due to senescence of the primary cell cultures, we are
currently attempting to obtain more patient 054 and 053 fibroblasts.
Nuclear and cytoplasmic fractions were prepared as described previ-
ously for analysis of mRNA in patient fibroblasts (Genovese and Rowe,
1987; Stover et al., 1993). In brief, cultures were scraped into 10 ml of cold
PBS, centrifuged, and resuspended in 15 ml of lysis buffer (10 mM Tris,
pH 7.5, 10 mM KCl, 1.5 mM MgCl
 
2
 
) containing 0.25% Triton X-100. The
pellet was disrupted by Dounce homogenization, and the suspension cen-
trifuged for 10 min at 2,200 
 
g
 
 and transferred to a 30-ml corex tube (cyto-
plasmic extract) containing 2.0 ml 10
 
3 
 
extraction buffer (10% SDS, 0.10 M
Tris, pH 7.5, 0.05 M EDTA, and 500 
 
m
 
g/ml of proteinase K). The nuclear
pellet was reextracted in lysis buffer with homogenization, and following
centrifugation combined with the first extract. The nuclear pellet was re-
suspended in 1
 
3
 
 extraction buffer and subsequent steps of RNA isolation
followed the SDS proteinase K protocol (Genovese et al., 1984).
 
RNase Protection and DNA Sequencing
 
Indirect RNase protection was done by hybridizing nuclear mRNA with
antisense sscDNA transcribed from HF404, a probe specifically designed
to protect RNA from exons 19–43 (Genovese et al., 1989). After RNase A
digestion the RNA fragments were electrophoresed in 1% agarose with
formaldehyde, blotted onto nitrocellulose, and hybridized (Genovese et al.,
1989). For direct RNase protection assays (Stover et al., 1993) a cRNA
probe of a PCR derived DNA fragment that includes exons 24–28 as well
as intron 26 was cloned into pBSII-SK
 
1
 
 (Stratagene) and hybridized to
nuclear and cytoplasmic mRNA. The hybrid solution was then incubated
with T2 RNase and the protected probe fragments identified by electro-
phoresis in a 6.0% denaturing polyacrylamide gel. Probes for direct
RNase protection were generated by reverse transcription and PCR am-
plification of nuclear RNA from 054 cells. Manual DNA sequencing was
performed with the Sequenase Reagent Kit (US Biochemical Corp).
 
RNA Half-life Determinations
 
One day before harvesting, cells were placed in fresh media containing 25
 
m
 
g/ml ascorbic acid. Inhibition of mRNA transcription was begun by ad-
justing the media to 25 mM 5,6-dichloro-1-(
 
D
 
-ribofuranosyl)benzimida-
zole (DRB), which blocks Pol II elongation and/or initiation (Chodosh
et al., 1989). Control cells were incubated in DRB for 0, 6, 9, and 12 h fol-
lowed by extraction of total RNA. Three plates of confluent cells were
used for each time point. COL1A1 mRNA levels were examined by
RNAase protection and quantitated with a Molecular Dynamics Phos-
phorImager. Multiple plates of 054 cells were incubated in 25 mM DRB
for 0, 4.5, and 9 h.
 
Fluorescence In Situ Hybridization
and Immunofluorescence
 
Cells were prepared for fluorescence in situ hybridization (FISH) as previ-
ously described (Lawrence et al., 1989; Carter et al., 1991; Johnson et al.,
1991). In brief, cells were washed in cytoskeletal buffer (CSK; Fey et al.,
1986) extracted with 0.5% Triton X-100, and fixed in 4% paraformalde-
hyde 1
 
3
 
 PBS (pH 7.4) for 8 min. Human collagen 1A1 DNA clones in-
cluded cosmid CG103 containing the entire 18-kb human gene (Barsh et
al., 1984), a 3
 
9
 
 1.8-kb partial cDNA clone, pHf677 (ATCC), and a 5.2-kb
full-length cDNA probe (ATCC). COL1A1 intron 26-specific probes
were generated by PCR. Two oligonucleotide probes, specific to intron
24, were end-labeled with biotin. Probes, including the PCR generated in-
tron 26, were nick translated with digoxigenin-11-dUTP or biotin-16-
dUTP (Boehringer). 2.5 
 
m
 
g/ml of probe was lyophilized with 10 
 
m
 
g each of
 
E
 
.
 
 coli
 
 tRNA, Salmon Sperm DNA and Human Cot I DNA, resuspended
in 100% formamide and heat denaturated before addition of hybridiza-
tion buffer to achieve 50% formamide and 2
 
3 
 
SSC. For hybridization to
RNA, probe was applied directly, but for DNA hybridization cellular
DNA was denatured in 70% formamide for 2 min at 70
 
8
 
C. A sequential
procedure was required to visualize RNA and DNA simultaneously (Xing
et al., 1995). This involved initial hybridization and detection of RNA
only, followed by fixation of that signal before proceeding with 0.07 N
NaOH denaturation to hydrolyze RNA and denature cellular DNA. The
DNA was then hybridized with a probe of identical sequence but different
label. Biotinylated probe was detected with FITC-avidin (Boehringer)
and digoxigenin probe with rhodamine-conjugated anti-digoxigenin (Boeh-
ringer). SC-35 immunofluorescence was performed using a mouse mono-
clonal antibody against the spliceosome assembly factor SC-35 (Sigma-
Aldrich; Fu and Maniatis, 1990), which may also detect another antigen
that colocalizes to the same nuclear domains (Fu et al., 1992).
 
Exon Suppression Hybridization
 
To visualize the collective distribution of intron-containing transcripts
within a given gene, a method was developed to simultaneously target all
intron sequences while excluding exon sequences. The exon suppression
hybridization technique, involves competing the hybridization of full-
length genomic probe with excess unlabeled full-length cDNA. This in-
volves a large excess of unlabeled cDNA in the hybridization reaction, af-
ter a prehybridization with unlabeled cDNA. 2 
 
m
 
g of full-length COL1A1
cDNA (cut to 
 
z
 
50–200 bp) was prehybridized to nondenatured WI-38
cells with probe mix also containing 10 
 
m
 
g each of salmon sperm DNA, 
 
E
 
.
 
coli
 
 tRNA, and human Cot 1 DNA for 2–16 h at 37
 
8
 
C in 50% formamide
and 2
 
3 
 
SSC. After three rinses, cells were hybridized a second time with
2.5 
 
m
 
g/ml of heat-denatured, digoxigenin-labeled full-length collagen 1A1
genomic probe, containing 4 
 
m
 
g of unlabeled full-length COL1A1 cDNA.
After rinsing, the collective intron signal was detected with rhodamine
anti-digoxigenin antibody. Control samples were treated identically, ex-
cept that the labeled probe was a full-length cDNA, (to ensure that no
exon sequences were detected). For colocalization of collective-intron sig-
nal with the cDNA track, an initial hybridization used labeled cDNA
probe, before proceeding with the exon suppression protocol.
 
Microscopy and Image Analysis
 
All results were observable directly through the microscope, without im-
age processing, and digital imaging was used to capture representative im-
ages and for microfluorimetric measurements. A Zeiss Axioplan micro-
scope was equipped with a triple-bandpass epifluorescence filter (Chroma
Technology, Inc.) and a custom-made color filter wheel, such that three
colors can be viewed simultaneously with no optical shift. Digital images
were captured with a Photometrics series 200 CCD camera (Photometrics,
Ltd.). Morphometry and microfluorimetry programs (G.W. Hannaway 
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and Associates or Universal Imaging Corp.) were adapted to determine
signal area, percent overlap of two signals, and total fluorescence or inten-
sity within a delineated area. Fluorescent intensity was determined after
subtraction of background fluorescence within each individual cell. Be-
cause of inherent variations between cells, comparisons were only made
between the two alleles within a single cell. Over 50 cells were randomly
photographed and measured for data analysis, with the only criteria for
selection being the presence of distinct RNA signal.
 
Results
 
Molecular Characterization of COL1A1 RNA in
O54 Cells
 
Cells from patient 054 with OI Type I were investigated to
determine the specific mutation in the COL1A1 gene, us-
ing procedures previously reported for OI Type I patient
053 (Stover et al., 1993). As described below, results
showed a splice-junction defect that proved identical to
that previously seen for patient 053. Initial evidence of a
retained intron in patient 054 was obtained by indirect
RNase protection performed on nuclear and total RNA
extractions in patient and control cells (Fig. 1 A). The pri-
mary band at 1.8 kb, seen in all lanes, is the fully protected
RNA, colinear with the sscDNA probe derived from
HF404, which encompasses exons 19–43 (Stover et al.,
1993). However, in the nucleus of patient 054 (lane 1), a
1.4-kb and a weak 0.4-kb band were also present, indicat-
ing that one of the RNA species in these heterozygous
cells contains an insertion in the region encompassing
Hf404. Note that sometimes there was a very faint band
barely detectable at 
 
z
 
1.5 kb in normal cells (Fig. 1 A, lane
3, arrow); this represents a small fraction of nuclear tran-
scripts that still retain intron 24, which is removed late in
the splicing process (see below).
 
Precise identification of the mutant insertion was ob-
tained by first synthesizing a probe by RT/PCR of nuclear
RNA from cell strain 053 using oligonucleotide primers
derived from exons 24 and 28 (Stover et al., 1993). The 552
nt cRNA probe was then used for direct RNase protection
(Fig. 1 B). Hybridization to nuclear and cytoplasmic RNA
extracts in both patient and control cells produced bands
at 209 and 90 nt, indicative of the fully spliced exons 24–26
and 27, 28 from the normal allele. Only in the nuclear
fraction of 054 cells was there a distinct 442 nt band (Fig. 1
B, lane 3). This band (slightly smaller than the full probe
due to polylinker sequences in the cRNA) is consistent
with full protection by a mature RNA containing a re-
tained intron 26. This band is absent from the cytoplasmic
RNA of patient cells, as well as from the nuclear and cyto-
plasmic RNA of control cells. As exemplified here, the rel-
ative amount of the two lower bands in the 054 nuclear
RNA was often significantly less than the intron contain-
ing band, suggesting that this larger transcript may accu-
mulate within the nucleus. Genomic DNA isolated from
054 cells was cloned and sequenced (not shown), which
showed the identical mutation reported earlier for patient
053 (Stover et al., 1993), a G to A transition in the first po-
sition donor site of intron 26, which is associated with re-
tention of intron 26.
Failure of the mutant COL1A1 RNA transcript to ap-
pear in the cytoplasm could result from impaired export to
the cytoplasm or rapid degradation. To distinguish be-
tween these two possibilities, the rate of disappearance of
normal and mutant transcripts from the nucleus of cell
strain 054 was examined after inhibition of RNA synthesis
with 25 mM DRB (5,6-dichloro-1-
 
B
 
-
 
D
 
-ribofuranosyl benz-
imidazole), a specific RNA polymerase II inhibitor (Zan-
domeni et al., 1986). Control analysis using direct RNase
Figure 1. (A) Indirect RNase
protection by hybridization
of cellular RNA with HF404,
which encompasses COL1A1
exons 19–43. Nuclear mRNA
from heterozygous patient
054 contains the primary 1.8-
kb band, as well as a 1.4-kb
and a weak 0.4-kb band, indi-
cating the presence of an
insertion (lane 1). Nuclear
mRNA from a control pa-
tient (411), which lacks an in-
tron retention mutation (lane
2). Total RNA from control
cells (lane 3). Note the pres-
ence of a faint 1.5-kb band in
normal cells suggesting late
removal of intron 24 (see re-
sults). (B) Direct RNase pro-
tection. A 552-bp probe en-
compassing exons 24–28 and
intron 26, was generated by RT/PCR for hybridization to nuclear (lanes 1 and 3) and cytoplasmic (lanes 2 and 4) RNA from control
(lanes 1 and 2) and 054 (lanes 3 and 4) cells. Full protection of the 442-nt fragment was only seen in the nuclear compartment of cells
from patient 054 (lane 3) which is consistent with the retention of intron 26. Even when the sample is loaded so that processed mRNA is
abundantly detected in the nuclear fraction, the unprocessed intermediate is undetectable (lane 1). The smaller 209- and 90-nt bands
represent the fully spliced exons 24–26 and 27, 28. (C) Nuclear retention of COL1A1 RNA. Transcription was inhibited in 054 cells us-
ing DRB and the proportion of normal and mutant COL1A1 transcripts remaining in the nuclear fraction was quantitated by direct
RNase Protection, indicating a more stable population of mutant transcripts. 
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protection of total mRNA with the same exon 24–28
probe used above confirmed that the DRB conditions ade-
quately inhibited new COL1A1 mRNA production, and
suggested a cytoplasmic mRNA half life of 9 h, similar to
other reported values (Sandmeyer et al., 1981). The half-
life of COL1A1 nuclear RNA in DRB-treated cells was
then examined in 054 cells at 0, 4.5, and 9 h. If nuclear
transport is normal and cytoplasmic degradation rapid,
then equivalent half-lives in the nucleus for normal and
mutant transcripts would be predicted. As illustrated in
Fig. 1 C, the nuclear half-life of the mutant COL1A1 tran-
scripts is atypically long relative to the normal, with sub-
stantial mutant RNA present in nuclei up to 9 h, when
normal transcripts were no longer detectable. Similarly, in
a second DRB experiment (not shown), it took 2.5 h of
DRB treatment for the normal RNA to degrade 50% ver-
sus 4.0 h for the mutant RNA, and the ratio of mutant to
normal nuclear transcripts increased from 2.8 at 0 h DRB
to 5.2 after 9 h DRB. More experiments would be neces-
sary for precise determination of nuclear half-life, but
these results show that mutant transcripts are longer lived
in the nucleus than the normal, consistent with a defect in
RNA transport. Although the mutant transcripts contain
nonsense codons, they are clearly not under-represented
and rapidly degraded in the nucleus (see Discussion).
 
Normal and Mutant Transcripts Form Tracks in Nuclei 
of OI Cells
 
Having investigated the molecular basis for the patient
disease, we next undertook a direct visual examination of
both normal and mutant COL1A1 alleles to address where
within nuclear structure a transport block might occur.
This involved a series of molecular cytological analyses us-
ing procedures optimized for in situ detection of nuclear
RNAs and/or DNA (see Materials and Methods). Results
are based on analysis of hundreds of cells viewed directly
through an epifluorescence microscope, with digital imag-
ing used to capture representative photographs. In addi-
tion, we developed for this study an approach using mor-
phometry and microfluorimetry to objectively quantify
cytological results in large numbers of cells.
The impact of the intron retention mutation on
COL1A1 nuclear RNA distribution must be understood
relative to RNA from the normal gene, hence this is
briefly considered first, some aspects of which were pub-
lished previously (Xing et al., 1995). Collagen nuclear
RNA, detected with either a cDNA or genomic probe, is
generally distributed in two prominent nuclear accumu-
lations, with weak fluorescence often visible throughout
the nucleoplasm. As previously reported, this weaker
fluorescence appears as tiny punctate spots at the mar-
gin of sensitivity, possibly reflecting a broadly dispersed
distribution of individual molecules (Xing et al., 1995).
The prominent RNA accumulations are not linear but
typically have somewhat elongate or elliptical morphol-
ogy (Fig. 2, A, B, F, and H), between 0.5–3
 
 m
 
m in longest
dimension. In contrast, hybridization to the entire col-
lagen gene (
 
z
 
18 kb) produces a point signal of 
 
z
 
0.2 
 
m
 
m.
Using a procedure that allows simultaneous hybridiza-
tion of a full-length gene and its RNA in two distinct col-
ors (Xing et al., 1995), the gene consistently localizes to
one end of the RNA signal, which extends well beyond it
(Fig. 2 A).
To understand the implications of these results, it is
important to consider that any distance resolvable by fluo-
rescence microscopy is large from a molecular perspective,
given the 0.1–0.2-
 
m
 
m limit of resolution. Hence, the
COL1A1 RNA accumulations are substantially larger than
the full-length gene (which may well be smaller than the
 
z
 
0.2-
 
m
 
m signal it generates, see Fig. 6 B legend). Hence,
we will refer to these RNA accumulations as tracks, de-
fined previously to indicate a posttranscriptional RNA ac-
cumulation that extends beyond and to one side of the
gene (Lawrence et al., 1989; Xing et al., 1993; Xing and
Lawrence, 1993). Further evidence is considered below
that these tracks represent detached transcripts in transit
from the gene, as distinct from nascent transcripts on the
gene (a tree). COL1A1 RNA tracks are more globular
than the highly linear viral RNA tracks in some cell types
(Lawrence et al., 1988), and normal COL1A1 RNA tracks
do not extend to the nuclear envelope (Xing et al., 1995).
A priori it was not known whether mutant transcripts
would also form tracks like the normal RNA. For example,
if the splice-junction defect blocks transcripts directly at or
on the gene, then we would predict that RNA from the mu-
tant allele would not form a track-like accumulation, but a
smaller spot, likely brighter than the gene signal but of sim-
ilar dimension. As illustrated in Fig. 2, B and C, COL1A1
transcripts visualized with a 1.8-kb cDNA probe in both
WI38 and 054 cells, generally showed two elongated nu-
clear RNA tracks. Digital morphometry of RNA accumu-
lations in a large sample (Fig. 3, A and B) indicated that
track size was not markedly or consistently different in nor-
mal and mutant cells. However, in 054 cells the data gener-
ally are shifted slightly to the right, and there was more
variability in size and intensity of RNA from the two al-
leles. This provided a preliminary suggestion that the mu-
tant tracks might contain more RNA; but because there is
also some variability between normal alleles, it could not
be confidently concluded on this basis alone that mutant
and normal tracks were distinguishable. The fact that RNA
tracks in 054 cells were clearly not smaller or less intense
than in WI38 cells indicates that the splicing mutation does
not cause an accumulation of RNA directly at the gene,
since both RNA signals extended well beyond the size of
the gene signal (see below). Nor does the splice defect ap-
parently result in rapid degradation of transcripts from the
mutant allele, consistent with the above RNase Protection
and half-life analysis, since substantial RNA accumulations
were present with both alleles.
With regard to RNA distributions elsewhere in the nu-
cleus, there were no atypical accumulations of COL1A1
RNA apparent at the nuclear envelope, around or within
the nucleolus, or at other sites throughout the nucleo-
plasm. In some mutant 054 cells there were multiple very
weak patches of fluorescence signal in the nucleoplasm,
often near the mutant allele (see Fig. 2 J), although there
was also sometimes nucleoplasmic signal in normal cells
(discussed above). However, in all cases the most clear
and localized accumulations occurred in the highly con-
centrated primary RNA tracks. Further analysis was re-
quired to determine definitively if the mutant tracks dif-
fered from the normal. 
The Journal of Cell Biology, Volume 150, 2000 422
Figure 2. Fluorescent in situ hybridization using COL1A1 genomic, cDNA and intron 26 specific probes in normal and patient 054 fi-
broblasts. (A) Collagen transcripts (red) detected with a digoxigenin-labeled full-length genomic probe extend beyond and to the side
of the gene, detected with the same probe sequence labeled with biotin (green). (B and C) Nuclear RNA tracks detected with a 1.8-kb
39 end cDNA probe in (B) W138 and (C) 054 cells. (D and E) Intron 26 RNA in (D) W138 and (E) 054 cells. Arrow indicates small in-
tron 26 signal associated with normal allele. (F, G, H, I, and J) Colocalization of intron 26 (red) and the cDNA track (green, overlap of
red and green appears yellow). (F and H) Small intron 26 signal (arrows) localizes to the end of the cDNA track in W138 cells. An en-
largement of the tracks (H) shows that intron 26 has been removed from a portion of the track. (G and J) In 054 cells, the normal cDNA
track (arrow) is polar with respect to intron 26, whereas the other track is not, thus enabling identification of the mutant allele. (I)
Higher magnification view of the retained intron 26 (red) completely colocalizing with the cDNA track from one allele in heterozygous
mutant cells (green). (J) Illustrates patchy secondary signal sometimes observed in 054 cells, often near the mutant allele (see text).
Bars, (A, H and I) 1.3 mm; (B, C, D, E, and F) 5 mm; (G and J) 4 mm. 
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RNA Tracks from the Mutant Allele Lack Polarity for 
Intron 26
 
Possible differences between the normal and mutant RNA
accumulations might be more obvious from the distribu-
tion of intron 26, which is retained in the mutant primary
transcript. As illustrated in Fig. 2 D, hybridization of an in-
tron 26–specific probe to normal WI-38 cells shows signal
in two small foci of similar size and intensity, clearly de-
tectable above background in most but not all cells. In
contrast, the intron 26 accumulations within heterozygous
054 nuclei differ markedly, with one a compact focus and
the other a larger track (Fig. 2 E). Fig. 3, C and E, summa-
rizes quantitation of areas from over 100 intron signals. In
heterozygous 054 cells, 45% of intron accumulations were
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, in contrast to only 1% in WI-38, and there was a
much greater difference in the areas between the two al-
leles per nucleus for 054 versus WI-38 (5.8 versus 0.73 
 
m
 
2
 
,
respectively). Similar differences were observed in cells
from patient 053 (not shown). These data suggest that the
larger intron track, unlike that seen in normal cells, could
be from the mutant allele. As illustrated in Fig. 2, E, G,
and J, the small normal intron focus was not brighter than
the intron signal throughout the mutant track, as expected
if the intron focus with the normal allele represents prima-
rily introns in pre-mRNA (i.e., rather than a pile-up of ex-
cised introns). As previously suggested, excised introns
Figure 3. Frequency distribu-
tion of COL1A1 RNA signal
areas in normal WI38 and
mutant 054 cells. Morpho-
metric data quantitates the
area of nuclear RNA accu-
mulations in large cell sam-
ples, with a minimum of 50
WI38 and 054 cells measured.
(A) cDNA in WI38 cells. (B)
cDNA in heterozygous 054
cells. The distribution re-
flects equal contributions of
the normal and mutant al-
lele. (C) Intron 26 in WI38
cells. (D) Collective intron in
WI38 cells representing hy-
bridization to all 50 introns in
the COL1A1 primary tran-
script using exon suppression
hybridization. The distribu-
tion is remarkably similar to
that seen for intron 26 alone
(C). (E) Intron 26 in 054 cells.
The mutant cells contain a
population of intron 26 tracks
which are much larger than
seen in normal cells (C).
Figure 4. Frequency distribu-
tion showing the percent
overlap of COL1A1 intron
signal with cDNA tracks.
Morphometric data was col-
lected on over 50 normal
W138 or mutant 054 cells by
outlining on the computer
each distinct signal in sepa-
rate color channels. (A) In-
tron 26 overlap with cDNA in
W138 cells. (B) Collective in-
tron overlap with cDNA in
W138 cells, note the distribu-
tions in A and B are very sim-
ilar. (C) Intron 26 and cDNA
overlap in heterozygous 054
cells. The 054 cells contain a
population of tracks which
have a much higher overlap than that seen in normal cells (A). (D and E) Overlap data from each individual cell was separated into the
allele with the smaller (open bar) versus larger (solid bar) overlap. (D) Separated alleles from W138 cells. (E) Separated alleles from
054 cells. The clear bimodal distribution demonstrates the presence of two distinct populations of RNA tracks in 054 cells, with the
higher overlap clearly reflecting the mutant allele. 
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may disperse widely (Zeitlin and Efstratiadis, 1984; Xing
et al., 1993), however, a diffuse distribution of small
COL1A1 introns is difficult to discern definitively from
background.
In normal fibroblasts, simultaneous detection of the
cDNA and intron probe in two different colors has shown
the intron 26 detected only at one end of the larger track
defined by cDNA hybridization (Fig. 2, F and H). This po-
lar distribution was interpreted to indicate splicing, re-
vealed by a distinct spatial arrangement of unspliced and
spliced transcripts as they progressed further from the
gene (Xing et al., 1993, 1995). If this spatial polarity is in-
deed indicative of splicing, then in 054 cells, tracks from
the mutant allele should lack this polarity. Over 100 RNA
tracks were examined qualitatively and quantitatively. In
WI-38 cells, both intron accumulations formed tiny foci to-
wards one end or one side of the cDNA track; rarely was
any trace of signal detectable throughout the rest of the
cDNA track. In contrast, the two RNA tracks within each
054 nucleus were clearly different, with one exhibiting the
normal polar distribution of intron 26 and the other show-
ing no such polarity. Instead, a bright intron 26 signal uni-
formly overlapped one entire cDNA track in patient cells
(see Fig. 2, G, I, and J).
The percent of the cDNA track containing colocalized
intron signal (% overlap) was calculated using digital mi-
crofluorimetry (Fig. 4, A and C). In 054 cells, 84% of cells
had a single RNA track with 
 
.
 
80% overlap, whereas no
control tracks fell in this range. This difference was further
demonstrated in Fig. 4, D and E, in which the two alleles
in each cell were separated into those with the larger or
smaller percent overlap. Unlike the WI-38 cells, the
marked bimodal distribution for 054 cells clearly reflects a
heterozygous cell with one normal and one splice-defec-
tive allele. These results establish that normal and mutant
COL1A1 tracks can be distinguished by direct microscopy
or quantitative digital imaging, within as little as a single
cell. Moreover, the nonpolar nature of RNA tracks from
the splice-defective allele proves that the polarity normally
observed reflects splicing and distinct morphological dis-
tributions of spliced and unspliced transcripts, for intron 26.
 
COL1A1 Introns Are Predominantly Spliced at One 
End of the RNA Track
 
An important potential implication of the above results is
that the splice-defective RNA does not back up directly at
the gene, but forms a track of molecules that we suggest
are largely released transcripts, reflecting an early step in
RNA export. Therefore, it is important to firmly establish
whether normal RNA tracks are simply accumulations of
nascent transcripts (a tree) on a highly distended gene, or,
alternatively, are comprised largely of detached transcripts
in movement from the gene (a track), perhaps progressing
from less to more mature transcripts. The distribution of
different intron sequences provides insights into the struc-
tural basis of the track and its relationship to splicing. The
Christmas tree model would predict a distribution of in-
trons along the length of the track in accordance with posi-
tion of sequences within a presumably highly distended
gene. (Such an intron distribution was recently reported
for nascent transcript trees along the huge dystrophin gene
 
[Smith et al., 1999].) The restriction of intron 26 to one
extremity of the COL1A1 cDNA track, as well as the
small size of the COL1A1 DNA, is most consistent with
the alternative model of posttranscriptional RNA tracks
(see Fig. 6); however, this one intron could be atypical of
the numerous introns in this highly complex primary tran-
script.
To investigate where splicing occurred for the various 50
COL1A1 introns and visualize their distribution presented
a technical challenge. A hybridization strategy was devised
that made it possible to visualize essentially all intron-con-
taining RNA from a given gene simultaneously, while ex-
cluding signal from exons (see Materials and Methods).
This exon suppression technique involves competing hy-
bridization of full-length genomic probe with excess unla-
beled full-length cDNA, such that only intron RNA se-
quences are available to hybridize labeled probe. The
collective intron thus reveals the summative distribution
of the 50 COL1A1 introns, which can then be analyzed rel-
ative to either the cDNA track or other nuclear structures.
Control samples confirmed that competition completely
suppressed exon signal, as no specific signal was observed
when the probe was a labeled cDNA (Fig. 5 C). In con-
trast, in the same experiment samples hybridized with full-
length genomic probe consistently resulted in a bright
focal signal, indicating that this derived from introns exclu-
sively. To examine this collective intron signal relative to
the cDNA track in distinct colors, hybridization with a bi-
otin-labeled cDNA probe was followed by exon suppres-
sion hybridization with digoxigenin-labeled genomic probe
(see Materials and Methods).
Examination of hundreds of normal cells in repeated ex-
periments revealed a small bright focus of collective in-
tron signal. This signal overlapped the cDNA track, but
was clearly smaller and generally concentrated at one end
or the periphery of the cDNA accumulation, similar to
intron 26 (see Fig. 5, A and B). Remarkably, the size of
the collective intron signal was not significantly different
from that for intron 26, nor was the extent of overlap with
the cDNA track (compare Fig. 3, C with D and Fig. 4, A
with B). Given that the signal will include some excised in-
trons as they disperse from the splicing site, the intron-
containing pre-mRNA may be even more tightly localized
than it appears here. The collective intron area averaged
1.24 
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80) as contrasted with 4.1 
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2
 
 for the cDNA.
Only rarely was any trace of collective intron signal dis-
cernible throughout the cDNA track. Since the complexity
of the probe used will be less efficient in the detection of
any one intron, we cannot conclude that all introns have
been removed. We can conclude that almost all introns
are removed in a tightly localized spot, consistent with
cotranscriptional splicing, with transcripts in the track pre-
dominantly spliced.
These findings counter the interpretation of the track as
merely nascent transcripts on a distended gene, and sup-
port the model of intact transcripts in an early stage of ex-
port (Fig. 6, model). A key point is that the COL1A1 tran-
scripts do not disperse equally in all directions, possibly
reflecting vectorial movement. Remarkably, the small fo-
cal concentration of intron 26 RNA, visualized simulta-
neously relative to the gene, can be resolved as slightly but
consistently concentrated to one side of the gene (see Fig. 
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Figure 5. Analysis of intron RNA distributions within COL1A1 RNA tracks and SC-35 domains, in normal WI38 cells. Exon-suppres-
sion hybridization was used to investigate the collective intron distribution (see Materials and Methods). (A and B) Colocalization of
collective intron (red) and cDNA (green). Most of the introns colocalize in a tight focus at the edge of the cDNA track. Only occasion-
ally is the intron signal elongated or diffuse (B, lower right). (C) cDNA tracks were completely competed away in control exon suppres-
sion experiments (compare with Fig. 2, B, F, and H). Colocalization of collective intron (red, D and E) or cDNA (red, F and H) with
SC35 domains (green). (D and E) The collective intron signal is concentrated at the edge of SC35 domains. Relatively little intron RNA
is detected throughout the central portion of the domain despite the comparatively high concentration of SC35. Graphs show the fluo-
rescence intensity for pixels along the line shown in blue (E). Note the sharp increase in SC-35 fluorescence at the boundary of an SC35
domain. (F and H) cDNA tracks (red) fill all or most of the SC35 domains with cDNA levels mirroring SC35 (H). (G) Colocalization of
intron 26 (red) and intron 24 (green). Intron 24 is removed late, and is retained throughout much of the RNA accumulation or track
from which intron 26 has already been removed. (I) Colocalization of intron 26 RNA (red) and the full-length COL1A1 gene (green).
Signal from intron 26 RNA partially overlaps the gene, but in 20 randomly chosen examples, was consistently displaced to one side. Bar,
(A, C, D, and I) 4 mm; (B and E, right most image) 1.3 mm; (E, left most image) 1 mm; (E, center image) 1.6 mm; (F and G) 3 mm; (H) 1 mm. 
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5 I). This further supports the model (Fig. 6) and suggests
the intriguing possibility that from the onset transcripts
emanate asymmetrically from the gene. Importantly, the
initial movement from the gene into the rest of the track
does not require complete splicing, since intron 26–con-
taining transcripts in OI cells also form a track.
 
Splicing at the Periphery of an SC-35 Domain with 
Essentially Spliced Transcripts throughout the Domain
 
If RNA molecules within the track are not localized because
they are bound to the gene, what is the structural basis for
these RNA accumulations? A key to understanding this lies
in the previous demonstration that in normal fibroblasts
COL1A1 RNA overlaps discrete intra-nuclear domains
enriched in SC-35, and that the gene consistently positions
at the edge of this domain (Xing et al., 1995). The above re-
sults showing collective intron signal at one end of the track
suggest indirectly that splicing of all of these COL1A1
RNA introns may also occur at the periphery of the SC-35–
rich domain. This point bears on a pivotal question: whether
the domain comprises just diffuse factors that are accumu-
lated via binding to COL1A1 introns, or whether the do-
main is a larger distinct entity, with which the gene associ-
ates and into which more mature transcripts enter after
transcription and splicing are essentially complete.
To address this directly the collective intron RNA signal
was investigated relative to the SC-35 domain, and, for
comparison, a similar analysis of cDNA was done. Fig. 5, D
and F, illustrates the marked differences in the extent of
overlap for each. Collective intron RNA occupied a clearly
smaller, more peripheral part of the SC-35 domain. In con-
trast, the cDNA signal was not restricted to the periphery
but occupied much more of the discrete SC-35–rich region,
having a somewhat similar morphology. Notably, the fac-
tors within most of the domain are in substantial excess of
the intron-containing transcripts. Fig. 5, E and H, shows
this by measuring the relative distributions of collective
intron or cDNA and SC-35 signal across the domain in a
series of cells. The histograms show the raw fluorescence
signal in individual pixels along the line indicated. The
 
Figure 6
 
. Early steps in nuclear transport of COL1A1 RNA,
models A and B, summarize results presented here and their in-
terpretation whereas Model C is more hypothetical. (A) Sche-
matic of normal and mutant COL1A1RNA tracks (intron 26 in
red and cDNA in green) and their progression through the nu-
cleus. An early step in the export of both normal and mutant
COL1A1 transcripts involves movement from the gene (blue)
into an SC35 domain (dark gray, step 1). Both properly spliced
(lower left track) and splice-defective RNA (upper track) accu-
mulate within the domain, but the mutant transcripts fail to un-
dergo the next step involving release from the domain and exit to
the rest of the nucleoplasm (step 2). The fully spliced normal
mRNA then traverses the nucleoplasm to the nuclear pore (step
3), which may involve more random dispersal of the RNA. A
later or final step in nuclear export would involve RNA translo-
cation through the nuclear pore (step 4). (B) Model showing the
RNA track as a posttranscriptional accumulation of predomi-
nantly spliced transcripts in an early stage of export. The collective
intron RNA (red) forms a focal signal at one end of the larger
RNA track detected by cDNA (green), which in turn is much
larger than the gene (blue) positioned at one end. The gene itself
is at the limits of resolution, and thus may be smaller than the 0.2-
 
m
 
m
fluorescent signal it generates. On a molecular scale, these tran-
scripts have moved an appreciable distance relative to the gene.
For COL1A1 RNA the track resides within an SC35 domain (not
necessarily the case for all RNA tracks). (C) Hypothetical model
showing a functional rationale for coupling the completion of
mRNA maturation and release for mRNA export with the recy-
cling/preassembly of factors within SC-35 domains. Because the
RNA metabolic machinery for processing and transcription re-
quires the interaction of such a large number of different factors,
their concentration at specific sites and preassembly into compo-
nents of a spliceosome or holoenzyme would facilitate recycling
and maintenance of a high rate of splicing. The RNA template is
synthesized at the periphery of the domain, and once released
from factors within the domain would be released for export and
the factors actively recycled at that site for rapid reuse. The
closer the completion of processing occurs to putative sites of re-
cycling the more efficient the total process. Further, if the time
required to recycle splicing factors is long relative to the time
they actually are engaged on the RNA, then sites of high splicing
activity might be associated with large accumulations of factors
not directly bound to unspliced RNA but engaged in dynamic re-
cycling.  
Johnson et al. 
 
Tracking RNA in Osteogenesis Imperfecta through SC35 Domains
 
427
 
peak fluorescence for collective intron signal drops sharply
in the periphery of the domain, whereas the SC-35 fluores-
cence remains uniformly high throughout, as does the cDNA
signal. Note that the SC-35 domain itself has discrete bound-
aries defined by a sharp increase in concentration, as does
the COL1A1 RNA track. These results demonstrate that
the majority of the introns within the collagen gene are re-
moved at the domain periphery and that transcripts enter-
ing the central regions are already predominantly spliced.
Further, since the vast majority of introns have already
been removed, the bulk of the factors that form the do-
main are not immediately bound to either splice-junction
sequences of COL1A1 introns or to excised introns. As
considered further below, the domain appears as a distinct
entity that contains both COL1A1 mRNA and excess fac-
tors, beyond those directly engaged on COL1A1 introns.
 
Mutant Transcripts Enter SC-35 Domains, but Their 
Exit Is Impeded
 
If intron 26 is normally removed before transcripts enter
the SC-35 domain, then it is possible that a defect in
splicing could prevent the RNA from distributing through
the domain and cause an abnormal RNA accumulation
outside it. Alternatively, if intron removal is necessary for
transcripts to exit the SC-35–rich domain, then mutant
transcripts might accumulate within this region. In fact, in
054 cells mutant transcripts accumulated within SC-35 do-
main as do normal transcripts (not shown). Transcripts
carrying a defect in splicing, therefore, extend into the SC-
35 domain, as do the normal transcripts. As noted above,
results suggested there might be more variability of track
size in the heterozygous mutant cells (Fig. 3 B), raising the
possibility that mutant tracks contain more transcripts. To
determine the relative numbers of transcripts from the
mutant and normal allele that accumulate within the track/
domain (irrespective of whether they are fully spliced) the
size and total fluorescence of cDNA signal for each was
quantitated and compared within individual 054 cells. Al-
though absolute measures of transcript number are less re-
liable, FISH does provide a means to determine the rela-
tive number of transcripts with each allele in each cell.
Because our analysis relies on comparison of normal and
mutant alleles within the same nucleus, technical varia-
tions are minimized.
As established above, mutant and normal tracks could
be discriminated based on the intron/cDNA overlap. Hence,
the cDNA signal associated with each allele was measured
to indicate the relative transcript number, and then the in-
tron/cDNA overlap was used to distinguish the normal
versus the mutant allele. This strategy was used to gener-
ate objective comparisons in a large sample of normal ver-
sus mutant tracks within each individual nucleus. The av-
erage area of the thus identified mutant track was 7.5 
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significantly larger than the normal RNA track, which was
5.2 
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 in 054 and 5.1 
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 in WI-38. Mutant transcripts also
were more concentrated within the track and throughout
the domain. In 
 
z
 
80% of cells the mutant track had higher
total intensity of cDNA signal. The total fluorescence sig-
nal in normal and mutant RNA tracks within each cell was
expressed as a ratio. The mean ratio of fluorescence
mRNA from the mutant versus normal RNA track in 054
cells was 2.1:1, with some mutant tracks having much
larger increases. No such significant difference was seen
for RNA tracks in WI-38 cells, where the average ratio was
close to one. The average twofold increase in mutant RNA
within the domain is consistent with other observations, in-
cluding the 2.8:1 ratio of mutant to normal transcripts by
RNase protection, and the change in nuclear ratio of
COL1A1 to 1A2 from 2:1 to 4:1 (Genovese and Rowe,
1987). We do not rule out that there could be some addi-
tional very dispersed mutant transcripts, however, the higher
RNA accumulations in the mutant track and domain indi-
cate that improperly spliced transcripts are impeded from
exiting this region. Since nuclear RNA accumulations dis-
perse and must be regenerated after each cell division (e.g.,
Carter et al., 1991; Clemson et al., 1996), the average mutant
RNA accumulation within the track might otherwise be
even greater. Hence, cells that have not recently divided
may be those with the largest mutant RNA accumulations,
which sometimes appear to spill into adjacent domains.
We conclude that mutant COL1A1 transcripts accumu-
late to abnormal levels within the track, with an average
twofold increase, and some mutant tracks showing sub-
stantially more. Furthermore, the site where this mutant
RNA accumulates is in the SC-35 domain.
 
Complete Splicing May Be Rate-limiting for Transcript 
Release from the SC-35 Domain
 
An impediment to transit from the SC-35 domain could
result directly from failure of the remaining splice-junction
sequence to be released from splicing factor complexes
within the domain, or could result less directly because
some subsequent step necessary for further transport of
mutant transcripts does not occur. The finding that RNA
from normal COL1A1 alleles also forms some accumula-
tion, a track within the domain, indicates that some slow
or rate-limiting step occurs there normally; this may be-
come more rate-limiting for the intron-retention mutant. If
the normal RNA were completely spliced before accumu-
lating within the domain, then this would suggest that
some step other than splicing must limit the rate of export
of normal RNA from the domain. Hence, it became im-
portant to address whether the COL1A1 RNA within the
track and domain was indeed completely spliced. We ad-
dressed this by examining the distribution of intron 24,
which RNase protection analyses suggested was removed
substantially later than most other introns, including in-
tron 26 (as may be apparent in Fig. 1, lane 3; Genovese et al.,
1989; Rowe, D., unpublished observations). To determine
if the temporal difference in splicing of this intron resulted
in a different spatial distribution of intron 24, introns 24
and 26 were examined simultaneously in two distinct col-
ors in normal WI-38 cells. As shown in Fig. 5 G, the distri-
bution of intron 24 is much more extensive than intron 26;
it is not confined to a tight focal accumulation as is intron
26 (and collective intron), but is detected as a larger accu-
mulation with a globular or elliptical morphology. Hence,
the late splicing of this intron is reflected in its morpholog-
ical distribution, indicating that it is not all spliced at the
periphery of the track and domain. Since the small (88 bp)
intron 24 represents 
 
z
 
1% of the total-intron signal, the
later splicing of this intron is not inconsistent with the find- 
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ing that the vast majority of COL1A1 introns are removed
at the domain periphery, likely cotranscriptionally. These
results directly show that COL1A1 transcripts continue to
mature as they transit away from the gene, with at least
this one intron apparently spliced posttranscriptionally at
some distance from the gene. Moreover, this finding makes
clear that, although transcripts entering the domain are
overwhelmingly spliced, completion of 100% of intron
splicing could still be the rate-limiting step in export of the
RNA from the domain.
 
Discussion
 
This study advances understanding of the relationship be-
tween nuclear structure and pre-mRNA metabolism, in
both normal cells and a specific genetic disease. Results
identify a previously undefined step in nuclear transport,
the point at which mutant transcripts become entrapped in
OI patient cells. Mutant transcripts do not accumulate at
the nuclear pore or nucleolus, or directly on the gene, but
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m from the gene within a specialized region of the
nucleoplasm highly enriched in numerous RNA metabolic
factors. Our results suggest that export of COL1A1 mRNA
can be broken down into several steps, which include: (a)
movement from the gene into the adjacent SC-35 domain,
generating an RNA track to one side of the gene, (b) pas-
sage (of normal transcripts) from the domain into the rest
of the nucleoplasm, (c) traversal through the nucleoplasm
to the nuclear envelope, and (d) translocation through the
pore to the cytoplasm (see Fig. 6 A). The significance of
the RNA distributions observed depend largely on our ob-
servations and interpretations of the structural basis for
RNA tracks and the SC-35 domain, hence these points will
be discussed in more detail first.
 
Tracks: an Accumulation of Predominantly Spliced and 
Released Transcripts Emanating to One Side of
the Gene
 
Perhaps due to the differences between various models
studied (see Introduction), there has remained some resis-
tance or confusion as to whether posttranscriptional RNA
tracks really exist, or whether localized RNA accumula-
tions are merely nascent transcripts still attached to the
gene. However, the differences seen for different RNAs are
not contradictory, but simply represent the complex bio-
logical realities, related to the differences in the relative
rates of different steps in RNA metabolism (discussed in
Shopland and Lawrence, 2000). Whether a track of post-
transcriptional transcripts is seen at all will be a function
not just of the RNA’s complexity, but likely reflects the
extent to which processing and transport keeps pace with
completion of transcription (Smith et al., 1999).
Because the point is critical to our overall conclusions,
we briefly summarize evidence that COL1A1 RNA tracks
are not just nascent transcripts on the gene, but primarily
spliced, detached transcripts at an early step in export
(Fig. 6 A). (a) The full-length gene signal is much smaller
(
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0.2–0.3 
 
m
 
) than the RNA signal (
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1–3 
 
m
 
 in longest di-
mension), and consistently positions to one side. (b) In-
tron 26 localizes with the gene, at one end of the larger
track (detected with full-length cDNA). In contrast, signal
 
with a 39 cDNA illuminates the larger track (as with full-
length cDNA). (c) The splice-defective RNA track shows
no polarity of intron 26, proving that the polarity does
reflect a distinct cytological arrangement of spliced and
unspliced transcripts. (d) An important point is that the
collective intron RNA signal (representing z50 introns
from across the gene) colocalize in a small spot (with in-
tron 26, at or near the gene). If the track represented na-
scent transcripts on distended DNA that escaped our de-
tection, the introns would distribute differently through
the track reflecting their location within the gene (as pre-
viously seen for nuclear RNA from the large dystrophin
gene, Smith et al., 1999). (e) Intron 24 is not restricted to a
spot-like signal at one end of the track, consistent with
other evidence that this intron is spliced slowly.
The accumulation of RNA to one side of the gene indi-
cates that a slow or rate-limiting step in RNA transport oc-
curs within the nucleoplasm, z1–3 m from the gene (dis-
cussed below). COL1A1 RNA tracks do not extend to the
nuclear envelope, but into a discrete region or SC35 do-
main (Xing et al., 1995). Upon leaving the track or domain
(Fig. 6 A, step 2), transcripts may either diffuse randomly
or move rapidly in some more directed process to the nu-
clear pore (step 3). As discussed previously, involvement
of structure or diffusion in RNA transport are not mutu-
ally exclusive possibilities (Xing et al., 1993; Daneholt,
1999; Shopland and Lawrence, 2000). We do not rule out
entirely that transcripts move in all directions from the
gene but accumulate only to one side. However, the find-
ing that even the intron 26 RNA signal is asymmetric rela-
tive to the gene strongly suggests that COL1A1 transcripts,
possibly even as they are transcribed, may emanate vecto-
rially to one side of the gene.
New Transcripts and Excess Factors within Domains
The track of COL1A1 transcripts extends into one of the
largest SC-35 domains in the nucleus. A straightforward
a priori explanation would be that splicing factors bind
to the many introns of this complex pre-mRNA accumu-
lated on the gene. However, several observations suggest
that the domain contains, in addition to new transcripts,
abundant excess factors not immediately bound to the 50
COL1A1 splice-junction sequences. Especially important,
almost all COL1A1 introns have already been removed at
the domain periphery, with essentially spliced transcripts
accumulated throughout the SC-35–rich region. This sup-
ports that the COL1A1-domain is not just diffuse factors
bound to unspliced transcripts, but a distinct (though re-
lated) structural entity, as suggested by earlier observa-
tions (Moen et al., 1995b; Xing et al., 1995). As we have
discussed previously, formation of the domain may be ini-
tiated due to the high demand for splicing factors and/or
the presence of a slow-splicing intron. However, we sug-
gest that the structural basis for the track of COL1A1
RNA becomes the SC-35 domain, not just visa versa. SC-
35 domains in general, like IGC, are discretely bordered
inter-chromatin structures which frequently reside be-
tween chromosome territories (Fakan and Puvion, 1980;
Carter et al., 1993; Visa et al., 1993; Zirbel et al., 1993) and
are highly resistant to detergent extraction and nuclear
fractionation (e.g., Blencowe et al., 1994,  reviewed inJohnson et al. Tracking RNA in Osteogenesis Imperfecta through SC35 Domains 429
Nickerson et al., 1995; Stein and Berezney, 1996). Simi-
larly, the COL1A1 RNA accumulation sits just outside its
parent chromosome territory and is preserved after deter-
gent or matrix extraction (Clemson et al., 1996). We con-
clude that COL1A1 RNA enters a specific region of the
nucleoplasm, an inter-chromatin domain containing both
excess factors and newly synthesized transcripts.
The Intra-nuclear Fate of Splice-defective COL1A1 
Transcripts in OI
Concerning mutant transcripts in OI, the first point dem-
onstrated is that transcripts retaining intron 26 do not rap-
idly degrade within the nucleus but accumulate there.
Despite downstream nonsense codons that might trigger
nonsense-mediated decay within the nucleus (see Willing
et al., 1996), these transcripts have a longer nuclear half-
life than normal. Although we cannot rule out that any
nonsense decay occurs, the retained intron may impede
further transport thereby circumventing nonsense medi-
ated decay, which may either be a cytoplasmic process for
COL1A1 RNA (as for yeast mRNAs), or may occur at the
nuclear envelope (Maquat, 1995; Jacobson and Peltz,
1996; Primorac et al., 1999).
Importantly, the splice-defective RNA does not accu-
mulate directly at or on the gene, but can detach and take
the first step into the domain. However the next step, tran-
sit from the domain, is blocked or slowed substantially
(Fig. 6 A, step 2). Although we sometimes see low levels
of dispersed transcripts in neighboring SC35 domains, our
results and very recent results of Custodio et al. (1999)
generally agree that splice-defective RNA does not accu-
mulate abnormally at the nuclear envelope, nucleolus or
randomly thru the nucleoplasm, but accumulates closer to
the gene. However, Custodio et al. (1999) forward a sig-
nificantly different interpretation: that transgenic mutant
RNA becomes trapped on the gene itself. Because the
small globin transgene is present in 14 tandem copies, it
would likely not be feasible to examine it with the detailed
resolution achieved here for COL1A1 DNA and RNA
(spliced and unspliced), and the relationship of globin trans-
genes to splicing factor domains was not examined. It is
also possible that the globin transgenes with just two in-
trons and integrated at an exogenous site may behave dif-
ferently than complex endogenous COL1A1 RNA.
Some checkpoint for COL1A1 RNA export apparently
occurs within the SC35 domain. We suggest that normal
COL1A1 RNA undergoes one or more maturation steps
there, and that splice-defective mutant transcripts do not
efficiently pass this point. We show that intron 24 is spliced
slowly within the domain, a slow-splicing intron may cause
the RNA accumulation within the SC-35–rich region.
Completion of splicing may be just one step required for
efficient transit, since factors or a holoenzyme within the
domain could also be involved in packaging or screening
the mRNA for export. Recent work shows that spliced
transcripts are packaged in a specific nucleoprotein com-
plex before export (Luo and Reed, 1999), and some fac-
tors involved (Blencowe et al., 1994) localize to SC-35
domains, as does an RNA helicase implicated in RNA
transport (Ohno and Shimura, 1996), and hsp 90 tran-
scripts containing no introns (Jolly et al., 1999).
We have considered the possibility that normal COL1A1
tracks comprise defective transcripts that have similarly
failed to pass this putative checkpoint. However, this is im-
plausible because it would suggest an error rate of z50%,
(normal tracks have about half as many transcripts), and
because mutant transcripts have a longer nuclear half-life.
Further, the dystrophin gene (74 introns) might be ex-
pected to have a higher error rate, yet no RNA track or
overlap with domains is seen (Smith et al., 1999).
A Rationale for Linking Factor Recycling within SC-35 
Domains with Release of mRNA for Export
We propose that within the COL1A1 domain several func-
tions related to RNA metabolism are spatially and func-
tionally integrated in a way that facilitates their efficiency
and coordination. The hypothetical model in Fig. 6 C de-
picts such a concept, suggesting that processing complexes
within the domain are actively engaged in recycling, closely
associated with mRNA maturation and release for RNA
export. In a process that requires interaction of .100 com-
ponents, the domain may serve to concentrate RNA meta-
bolic factors together to facilitate rapid recycling/preas-
sembly into spliceosomal subunits, to keep up with the high
demands of this (and possibly other) highly active genes.
The further from the domain completion of splicing and
disassembly occurs, the more disconnect and inefficient in
the reassembly and reuse. This suggests a functional ratio-
nale why COL1A1 RNA splicing and export may be linked
to a site of factor recycling. This cycle, in turn, is likely
controlled by phosphorylation (see Yeakley et al., 1999).
The COL1A1 domain could provide a more general par-
adigm for SC-35 domains. Although this remains to be de-
termined, these domains are indistinguishable by numer-
ous immuno-biochemical criteria, including enrichment with
poly A RNA (Carter et al., 1991), and may correspond to
IGC tightly juxtaposed with perichromatin fibrils (Xing et
al., 1995; Melcak et al., 2000). The abundance of 30-nm par-
ticles in IGC suggests some large preassembled complexes
in these structures (Fakan and Puvion, 1980; Reed et al.,
1988). Our hypothesis incorporates evidence from uridine
labeling studies that domains contain a disproportionate
excess of factors, but such studies do not conclusively show
these regions are devoid of new transcripts. In addition to
our findings, Bridge et al. (1996) reported adenovirus tran-
scripts in IGC, this group and Puvion’s discussed a possi-
ble role in export (Visa et al., 1993; see also Melcak et al.,
2000), and recently one study reported that speckles do in-
corporate BrUTP (Wei et al., 1999). In addition to the com-
plexities of extrapolating uridine label to pre-mRNA (Moen
et al., 1995b; Clemson and Lawrence, 1996), results here
reveal another important factor: 80% of label would be re-
moved from COL1A1 RNA before it enters the domain.
If spliced mRNAs destined for export enter domains, and
excised introns do not degrade immediately but release to
the inter-domain space (Qian et al., 1992; Xing et al., 1993),
then uridine label will underestimate numbers of transcripts
in the domain relative to the nucleoplasm. Hence, SC-35
domains could more generally be sites of rapid factor use/
recycling intimately associated with sites of high demand,
rather than comprise less active factors with distant rela-
tion to RNA metabolism. Our suggestion that domains con-The Journal of Cell Biology, Volume 150, 2000 430
tain active factors in rapid recycling is more consistent with
recent data from Phair and Misteli (2000) and Kruhlak et
al. (2000), showing that factors within domains turnover
with rates similar to those in the nucleoplasm (Shopland
and Lawrence, 2000).
In either case, results here show that an SC-35 domain is
important in screening and entrapping mutant COL1A1
RNA, which makes a critical difference in outcome be-
tween the mild Type I phenotype of patient 054 and severe
phenotypes of OI Types II and III.
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